| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Gilead Sciences, Inc. (GILD) has 11 insiders with recent SEC Form 4 filings, including 2 buys and 14 sells. GILD is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 626.3K | $79.13M | -15,000 | |
| Other | 46.9K | $5.93M | - | |
| Other | 46.6K | $5.89M | - | |
| VP | 44.2K | $5.58M | - | |
| Other | 27.9K | $3.52M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 31, 2025 | Dickinson Andrew D | Chief Financial Officer | Sale+OE | 142,180 | $97.22 | $13,822,739.60 | -52.3% | +6.2% | +46.0% | |
| Jan 15, 2025 | Dickinson Andrew D | Chief Financial Officer | Sell | 2,500 | $91.35 | $228,375.00 | -1.9% | +14.4% | +31.3% | |
| Dec 19, 2024 | Gilead Sciences, Inc.71 | 10% Owner | Buy | 940,499 | $21.37 | $20,098,463.63 | +74.1% | +18.0% | +36.4% | |
| Dec 18, 2024 | Gilead Sciences, Inc.71 | 10% Owner | Buy | 1,759,978 | $1.04 | $1,830,377.12 | +24.0% | +21.5% | +33.9% | |
| Dec 16, 2024 | Dickinson Andrew D | Chief Financial Officer | Sell | 8,500 | $91.96 | $781,660.00 | -6.0% | +22.0% | +29.0% | |
| Nov 29, 2024 | Dickinson Andrew D | Chief Financial Officer | Sale+OE | 248,645 | $92.76 | $23,065,270.54 | -38.0% | +21.0% | +35.9% | |
| Nov 27, 2024 | Parsey Merdad52 | Chief Medical Officer | Sale+OE | 164,211 | $91.92 | $15,094,013.40 | -22.9% | +20.7% | +36.2% | |
| Nov 26, 2024 | Bluestone Jeffrey | Director | Sale+OE | 6,788 | $91.39 | $620,356.00 | -43.2% | +21.5% | +39.6% | |
| Nov 6, 2024 | Parsey Merdad52 | Chief Medical Officer | Sale+OE | 25,590 | $91.50 | $2,341,485.00 | -11.1% | +6.9% | +34.6% | |
| Nov 6, 2024 | Mercier Johanna | Chief Commercial Officer | Sell | 5,000 | $91.28 | $456,400.00 | -6.4% | +6.9% | +34.6% |